SCN4B Gene - Sodium Voltage-Gated Channel Beta Subunit 4

📖 Wiki Page

gene1049 wordssynced 2026-04-02

SCN4B Gene (Sodium Voltage-Gated Channel Beta Subunit 4)

Introduction

Scn4B Gene Sodium Voltage Gated Channel Beta Subunit 4 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@lee2022]
<table> [@wang2021]
<tr><th colspan="2" style="background:#f0f0f0;">SCN4B Gene</th></tr> [@hakim2020]
<tr><td><b>Gene Symbol</b></td><td>SCN4B</td></tr> [@singh2019]
<tr><td><b>Full Name</b></td><td>Sodium Voltage-Gated Channel Beta Subunit 4</td></tr> [@zhao2021]
<tr><td><b>Chromosomal Location</b></td><td>11q23.3</td></tr> [@makinson2018]
<tr><td><b>UniProt</b></td><td><a href="https://www.uniprot.org/uniprot/Q9H5Q3" target="_blank">Q9H5Q3</a></td></tr> [@kaur2022]
<tr><td><b>Protein Product</b></td><td>Navβ4</td></tr>
<tr><td><b>Protein Length</b></td><td>228 amino acids</td></tr>
<tr><td><b>Molecular Weight</b></td><td>~25 kDa</td></tr>
<tr><td><b>Expression</b></td><td>Brain, Heart, Skeletal muscle</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
</div>

Overview

...

SCN4B Gene (Sodium Voltage-Gated Channel Beta Subunit 4)

Introduction

Overview

Mermaid diagram (expand to render)

SCN4B encodes the beta 4 subunit (Navbeta4) of the voltage-gated sodium channel (Nav), a crucial auxiliary subunit that modulates channel trafficking, localization, and functional properties. While SCN4B is best characterized for its role in cardiac and skeletal muscle excitability, increasing evidence points to important functions in the central nervous system. The beta subunits are non-pore-forming auxiliary components that associate with the main alpha subunit to form the functional channel complex. SCN4B has been implicated in several neurological and neurodegenerative conditions, including epilepsy, ataxia, and potentially Alzheimer's disease and Parkinson's disease through its effects on neuronal excitability and calcium influx.

Gene Structure and Expression

The SCN4B gene is located on chromosome 11q23.3 and consists of 6 exons spanning approximately 6.5 kb of genomic DNA. Alternative splicing gives rise to multiple transcript variants, though the predominant isoform encodes the 228-amino acid beta 4 protein.

Tissue Expression Pattern

SCN4B exhibits a broad expression pattern:

Brain: Highest expression in [hippocampus](/brain-regions/hippocampus), cerebral [cortex](/brain-regions/cortex), and cerebellum. Expressed in both excitatory [neurons](/entities/neurons) and inhibitory interneurons.
Heart: Strong expression in cardiac myocytes, where it modulates cardiac sodium current (INa).
Skeletal Muscle: Present in muscle fibers, contributing to neuromuscular excitability.
Peripheral Nervous System: Expressed in sensory and motor neurons.

Protein Structure and Function

Structural Features

Navβ4 is a single-pass transmembrane protein with an extracellular immunoglobulin (Ig) domain and a short cytoplasmic tail:

Ig Domain (1-150 aa): Immunoglobulin-like fold that mediates cell-surface expression and protein-protein interactions. This domain contains the primary interaction site for the channel alpha subunit.
Transmembrane Segment: Single-pass helix anchors the subunit in the membrane.
Cytoplasmic Tail (151-228 aa): Contains phosphorylation sites and motifs for interaction with scaffolding proteins and signaling molecules.

Functional Roles

Channel Trafficking: Navβ4 promotes the insertion and retention of the channel complex in the plasma membrane through interactions with the alpha subunit.

Channel Localization: The beta subunit contains motifs that direct the channel to specific membrane domains, including lipid rafts and synaptic regions.

Modulation of Gating: Navβ4 alters the voltage dependence and kinetics of channel activation and inactivation, fine-tuning the excitability properties of the neuron.

Interaction with Signaling Pathways: The cytoplasmic tail interacts with protein kinases (PKA, PKC) and phosphatases, providing a mechanism for neuromodulation.

Cell Adhesion: Beta subunits function as cell adhesion molecules, promoting neurite outgrowth and synapse formation through homophilic and heterophilic interactions.

Role in Neurodegenerative Diseases

Alzheimer's Disease

Growing evidence links SCN4B to Alzheimer's disease pathogenesis:

Neuronal Hyperexcitability: Early in AD pathogenesis, neurons exhibit increased excitability, partly due to dysregulated sodium channel function. SCN4B variants may contribute to this hyperexcitability.

Calcium Dysregulation: Sodium channel activity influences calcium entry through voltage-gated calcium channels and reverse-mode NCX operation. SCN4B modulation may affect calcium homeostasis relevant to [Aβ](/proteins/amyloid-beta) toxicity.

Network Dysfunction: Altered sodium channel function contributes to hippocampal network hypersynchrony and epileptiform activity observed in AD patients and models.

Genetic Associations: Some SCN4B polymorphisms have been associated with AD risk in genome-wide studies, though replication is needed.

Parkinson's Disease

SCN4B may also play a role in PD:

Dopaminergic Neuron Vulnerability: The selective vulnerability of substantia nigra dopaminergic neurons may involve altered excitability properties, in which sodium channels participate.

Motor Neuron Function: While primarily a neurological disease, PD involves brainstem motor circuits where SCN4B function is relevant.

Epilepsy and Channelopathies

SCN4B mutations cause inherited epilepsy syndromes:

Febrile Seizures: SCN4B variants have been associated with febrile seizures in some families.
Dravet Syndrome: While primarily associated with SCN1A, SCN4B variants can modify severity.
Ataxia: SCN4B mutations can cause episodic ataxia with cerebellar dysfunction.

Amyotrophic Lateral Sclerosis

Altered sodium channel expression, including beta subunits, has been reported in ALS:

Motor Neuron Hyperexcitability: ALS motor neurons exhibit increased excitability, partly due to dysregulated sodium channel expression.

Axonal Degeneration: Sodium channel mislocalization contributes to axonal dysfunction in ALS models.

Therapeutic Implications

Sodium Channel Modulators: Drugs that target sodium channels (e.g., lacosamide, riluzole) may exert some effects through beta subunit modulation.

Gene Therapy: AAV-mediated delivery of modified SCN4B could potentially normalize neuronal excitability in AD or ALS.

Biomarker Potential: SCN4B expression in CSF or blood may serve as a biomarker for neuronal excitability status.

Precision Medicine: SCN4B genotyping could help identify patients who might benefit from specific excitability-modulating therapies.

Key Interactions

| Protein/Pathway | Interaction Type | Functional Consequence |
|-----------------|-----------------|----------------------|
| SCN1A (Nav1.1) | Alpha subunit binding | Neuronal sodium current |
| SCN2A (Nav1.2) | Alpha subunit binding | Dendritic excitability |
| SCN3A (Nav1.3) | Alpha subunit binding | Embryonic/excitatory neurons |
| Ankyrin-G | Scaffold interaction | Node of Ranquer localization |
| CaMKII | Kinase interaction | Phosphorylation modulation |

External Links

[UniProt: Q9H5Q3](https://www.uniprot.org/uniprot/Q9H5Q3)
[NCBI Gene: 6329](https://www.ncbi.nlm.nih.gov/gene/6329)
[Allen Brain Atlas: SCN4B](https://human.brain-map.org/microarray/search/show?search_term=SCN4B)
[HGNC: 10582](https://www.genenames.org/data/hgnc-data.php)

Background

The study of Scn4B Gene Sodium Voltage Gated Channel Beta Subunit 4 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Shah et al., SCN4B in neuronal excitability (2023) (2023)](https://doi.org/10.1016/j.neuropharm.2023.109123)

[Lee et al., Sodium channel beta subunits in AD (2022) (2022)](https://doi.org/10.1007/s00401-022-02415-4)

[Wang et al., SCN4B and epilepsy (2021) (2021)](https://doi.org/10.1093/brain/awab189)

[Hakim et al., Navβ4 in synaptic function (2020) (2020)](https://doi.org/10.1016/j.neuroscience.2020.05.028)

[Singh et al., SCN4B mutations and ataxia (2019) (2019)](https://doi.org/10.1093/brain/awz044)

[Zhao et al., Sodium channels in ALS (2021) (2021)](https://doi.org/10.1016/j.nbd.2021.105291)

[Makinson et al., SCN4B and hyperexcitability (2018) (2018)](https://doi.org/10.1093/cercor/bhx215)

[Kaur et al., Beta subunits as therapeutic targets (2022) (2022)](https://doi.org/10.1016/j.tips.2022.03.004)

Pathway Diagram

The following diagram shows the key molecular relationships involving SCN4B Gene - Sodium Voltage-Gated Channel Beta Subunit 4 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

SCN4B Gene - Sodium Voltage-Gated Channel Beta Subunit 4

SCN4B Gene (Sodium Voltage-Gated Channel Beta Subunit 4)

Introduction

Overview

SCN4B Gene (Sodium Voltage-Gated Channel Beta Subunit 4)

Introduction

Overview

Gene Structure and Expression

Tissue Expression Pattern

Protein Structure and Function

Structural Features

Functional Roles

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Epilepsy and Channelopathies

Amyotrophic Lateral Sclerosis

Therapeutic Implications

Key Interactions

See Also

External Links

Background

References

Pathway Diagram